Getinge limits sale of heart devices in the US after FDA warning
(Reuters) - Sweden's Getinge will limit sales of some of its heart products in the U.S., the medical equipment maker said lat...
9h ago
Roche says FDA approves HPV self-test in US
BERLIN (Reuters) - Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human p...
10h ago
Taiwan says WHO should let it attend all its meetings
TAIPEI (Reuters) - Taiwan Foreign Minister Joseph Wu called on the World Health Organization on Wednesday to allow the island...
13h ago
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
(Reuters) - Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis...
16h ago
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular di...
18h ago
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
By Svea Herbst-Bayliss (Reuters) - Activist investor Jana Partners built a new stake in U.S. diagnostics company QuidelOrtho ...
19h ago
Grifols swings to profit, says debt reduction on track
By Joan Faus BARCELONA (Reuters) - Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 mil...
21h ago
CDC makes public influenza A wastewater data to assist bird flu probe
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday released data on influenza A found in wastew...
May 14, 2024
US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
(Reuters) - The U.S. Food and Drug Administration has declined to approve the expanded use of Dynavax Technologies' hepatitis...
May 14, 2024
Bayer's Q1 adjusted profit beats analyst consensus
FRANKFURT (Reuters) - Bayer on Tuesday reported a 1.3% decline in adjusted earnings in the first quarter, beating analysts' f...
May 14, 2024